An institute in Wuhan, under the China National Biotec Group (CNBG), a subsidiary of Sinopharm, has isolated the Delta variant of the novel coronavirus and is accelerating development on Delta-specific vaccines, its director told the media. The new Delta variant spread to Wuhan after about a year of...More

Chinese COVID-19 vaccine producers Sinopharm and Sinovac reached advance purchase agreements with the Global Alliance for Vaccines and Immunization (GAVI) to provide as many as 550 million doses of China-made vaccines for the world through the COVAX Facility, a move that would largely help the world tackle the...More

The grave epidemic situation in India, the world's largest vaccine producer, the WHO's approval of Chinese vaccines for emergency use, lingering questions on whether the US can really deliver its promise to provide vaccines to the world, all these have led to a widely acknowledged situation that China...More

A Chinese vaccine maker has begun COVID-19 vaccine clinical trials on minors to better understand the vaccine's safety and efficacy to a wider population, the Global Times learned on Tuesday. The China National Biotec Group (CNBG) of SinoPharm, China's leading vaccine producer with two inactivated vaccine candidates for...More